Abstract
With the huge market potential for testosterone therapy, information regarding the long-term health effects of AAS administration is of paramount importance.
Aim
The present study addresses the effects of such prolonged administration of supraphysiological AAS doses on cholesterol subfractions and apolipoproteins.
Methods
Subjects were divided into four distinct groups; (A) AAS users (n 8) who were still using at time of testing; (B) AAS users (n 8) who had been abstinent for a period greater than three months (mean SD: 5 2.3 months), (C) bodybuilding controls
(n 8) who did not use any pharmacological ergogenic aids, and (D) sedentary male controls (n 8). AAS use was confirmed through the measurement of Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Sex Hormone Binding Globulin. Data was analysed using the SPSS version 10.0 for Windows statistics package using appropriate statistics.
Results
HDL, Apo-AI and Apo-AII were significantly lower, whereas LDL and Apo-B were significantly higher in the AAS-On group, compared with the non-AAS using groups.
Conclusion
This level of HDL depression is consistent with many previous reports assessing HDL-C in bodybuilders self-administering AAS. Although definitive mechanisms are unknown, the enzyme Hepatic Triglyceride Lipase is thought to play an important role in the catabolism of HDL. However, the lack of a significant
difference between both groups of AAS users for both Apo-AI and Apo-AII suggests that androgen induced decrements may be more prolonged following the long-term administration of these drugs.
Aim
The present study addresses the effects of such prolonged administration of supraphysiological AAS doses on cholesterol subfractions and apolipoproteins.
Methods
Subjects were divided into four distinct groups; (A) AAS users (n 8) who were still using at time of testing; (B) AAS users (n 8) who had been abstinent for a period greater than three months (mean SD: 5 2.3 months), (C) bodybuilding controls
(n 8) who did not use any pharmacological ergogenic aids, and (D) sedentary male controls (n 8). AAS use was confirmed through the measurement of Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Sex Hormone Binding Globulin. Data was analysed using the SPSS version 10.0 for Windows statistics package using appropriate statistics.
Results
HDL, Apo-AI and Apo-AII were significantly lower, whereas LDL and Apo-B were significantly higher in the AAS-On group, compared with the non-AAS using groups.
Conclusion
This level of HDL depression is consistent with many previous reports assessing HDL-C in bodybuilders self-administering AAS. Although definitive mechanisms are unknown, the enzyme Hepatic Triglyceride Lipase is thought to play an important role in the catabolism of HDL. However, the lack of a significant
difference between both groups of AAS users for both Apo-AI and Apo-AII suggests that androgen induced decrements may be more prolonged following the long-term administration of these drugs.
| Original language | English |
|---|---|
| Pages (from-to) | 615-615 |
| Number of pages | 1 |
| Journal | Annals of Nutrition and Metabolism |
| Volume | 47 |
| DOIs | |
| Publication status | Published - 2003 |
| Externally published | Yes |
